Biotech News
Elutia to Report Fourth Quarter 2025 Financial Results on Wednesday, March 11, 2026
investors.elutia.com2026-05-06 15:15 EST
GAITHERSBURG, Md., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced that it will release its fourth quarter 2025 financial results after market close on Wednesday, March 11, 2026.